Genomictree Market Cap

Genomictree has a market cap or net worth of 576.54 billion as of January 16, 2026. Its market cap has increased by 3.59% in one year.

Market Cap

576.54B

Enterprise Value

493.71B

Revenue

3.76B

Ranking

n/a

PE Ratio

n/a

Stock Price

24,000.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 576.54B, an increase of 877.20%. That is a compound annual growth rate of 29.61%.

Market Cap History

Date	Market Cap	% Change
Jan 16, 2026	629.39B	-4.55%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	90.13T
Celltrion	45.73T
ALTEOGEN	27.70T
ABL Bio	10.89T
SK Biopharmaceuticals	9.43T
Yuhan	8.05T
HLB Co., Ltd.	6.97T
Sam Chun Dang Pharm.	6.49T

Market Cap Rankings